Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients

BACKGROUND: Biochemical recurrence (BCR) after initial treatment, such as radical prostatectomy, is the most frequently adopted prognostic factor for patients who suffer from prostate cancer (PCa). In this study, we aimed to construct a prognostic model consisting of gene expression profiles to pred...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yiqiao, Tao, Zijia, Li, Lei, Zheng, Jianyi, Chen, Xiaonan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896158/
https://www.ncbi.nlm.nih.gov/pubmed/35246070
http://dx.doi.org/10.1186/s12885-022-09331-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896158/
https://www.ncbi.nlm.nih.gov/pubmed/35246070
http://dx.doi.org/10.1186/s12885-022-09331-8

Ejemplares similares